Table 6.
Exosomes | Sensor Specification | Method | Sensing Strategy | Sample Matrices | Detection Range | Limit of Detection (LOD) | Ref. |
---|---|---|---|---|---|---|---|
MCF-7 exosomes | Apt./2D Ti3C2 MXenes nanosheets | Electrogenerated chemiluminescence (ECL) | sandwich-type | serum | 5 × 102–5 × 106 particles μL−1 | 125 particles μL−1 | [137] |
hepatocellular exosomes | Apt.-nanotetrahedron (NTH) SAM/Au electrode | SWV [Fe(CN)6]−3/−4 |
sandwich-type | membrane proteins | 105–1012 exosomes/mL | 1 × 104/mL | [138] |
exosomes | exosome transmembrane protein CD63 apt./Au electrode array, microfluidic system | SWV MB redox label |
switch-off | fetal bovine serum | 1 × 108 particles/mL | 1 × 106 particles/mL | [139] |
tumor exosomes LNCaP cells | DNAs/Au electrode | DPV Ru(NH3)63− signal reporter |
“turn-off” signal | MCF-7 cell, HeLa cell-derived exosomes | 1000–120,000 particles/µL | 70 particles/µL | [140] |
Exosomes | CD63 apt./GCE/Cu (I)-catalyzed click chemistry | DPV HRP, o-phenylene-diamine (OPD), H2O2 |
label-free | human serum | 1.12 × 102 to 1.12 × 108 particles/μL | 96 particles/μL | [141] |
cancer-exosome | ITO electrode | DPV DOX redox-active indicator |
label-free “signal-on” strategy |
biological, clinical samples | 3.4 × 104–3.4 × 108 particles per mL | 1.2 × 104 particles per mL | [142] |
HepG2-exosomes | Au electrode/apt. | SWV [Fe(CN)6]−3/−4 |
displacement reaction | serum samples | 1 × 105–5 × 107 particles/mL | 1.72 × 104 particles/mL | [143] |
CD63 positive exosomes | ITO electrode microfluidic on-chip platform (ExoPCD-chip) |
DPV [Fe(CN)6]−3/−4, th. enhanced cathodic current |
label-free | human serum and liver cancer patients, healthy controls | 7.61 × 104 particles/mL to 7.61 × 108 particles/mL | 4.39 × 103 particles/mL | [144] |